Louis Lefebvre

Louis Lefebvre

Auto-generated profile, based on publicly available information

Louis Lefebvre

Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1998 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
LLLouis Lefebvre
Louis Lefebvre
SVStéphane Viville
Stéphane Viville
SBSheila C. Barton
Sheila C. Barton
FIFumitoshi Ishino
Fumitoshi Ishino
EKEric B. Keverne
Eric B. Keverne
MSM. Azim Surani
M. Azim Surani

1 November 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MTMasako Tada
Masako Tada
TTTakashi Tada
Takashi Tada
LLLouis Lefebvre
Louis Lefebvre
SBSheila C. Barton
Sheila C. Barton
MSM. Azim Surani
M. Azim Surani
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 September 2014 in Genes & Development
Verified
Journal Article
Open access
PDF file
SLSheng Liu
Sheng Liu
JBJulie Brind’aMour
Julie Brind’aMour
MKMohammad M. Karimi
Mohammad M. Karimi
KSKenjiro Shirane
Kenjiro Shirane
ABAaron Bogutz
Aaron Bogutz
MLMatt Lorincz
Matt Lorincz
Transcription of endogenous retroviruses (ERVs) is inhibited by de novo DNA methylation during gametogenesis, a process initiated after birth in oocytes and at approximately embryonic day 15.5 (E15.5) in prospermatogonia. Earlier in germline development, the genome, including most retrotransposons, is progressively demethylated. Young ERVK and ERV1 elements, however, retain intermediate methylation levels. As DNA methylation reaches a low point in E13.5 primordial germ cells (PGCs) of both sexes, we determined whether retrotransposons are marked by H3K9me3 and H3K27me3 using a recently developed low-input ChIP-seq (chromatin immunoprecipitation [ChIP] combined with deep sequencing) method. Although these repressive histone modifications are found predominantly on distinct genomic regions in E13.5 PGCs, they concurrently mark partially methylated long terminal repeats (LTRs) and LINE1 elements. Germline-specific conditional knockout of the H3K9 methyltransferase SETDB1 yields a decrease of both marks and DNA methylation at H3K9me3-enriched retrotransposon families. Strikingly, Setdb1 knockout E13.5 PGCs show concomitant derepression of many marked ERVs, including intracisternal A particle (IAP), ETn, and ERVK10C elements, and ERV-proximal genes, a subset in a sex-dependent manner. Furthermore, Setdb1 deficiency is associated with a reduced number of male E13.5 PGCs and postnatal hypogonadism in both sexes. Taken together, these observations reveal that SETDB1 is an essential guardian against proviral expression prior to the onset of de novo DNA methylation in the germline.

29 April 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
QXQianhua Xu
Qianhua Xu
YXYunlong Xiang
Yunlong Xiang
QWQiujun Wang
Qiujun Wang
LWLeyun Wang
Leyun Wang
JBJulie Brind’aMour
Julie Brind’aMour
WXWei Xie
Wei Xie

20 May 2005 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
KKK A Kaiser-Rogers
K A Kaiser-Rogers
DMD E McFadden
D E McFadden
CLC A Livasy
C A Livasy
JDJ Dansereau
J Dansereau
RJR Jiang
R Jiang
WRWendy Robinson
Wendy Robinson
Background: Placental mesenchymal dysplasia (PMD) is a distinct syndrome of unknown aetiology that is associated with significant fetal morbidity and mortality. Intrauterine growth restriction is common, yet, paradoxically, many of the associated fetuses/newborns have been diagnosed with Beckwith-Wiedemann syndrome (BWS). Methods: We report two cases of PMD with high levels of androgenetic (complete paternal uniparental isodisomy) cells in the placenta and document, in one case, a likely androgenetic contribution to the fetus as well. Results: The same haploid paternal complement found in the androgenetic cells was present in coexisting biparental cells, suggesting origin from a single fertilisation event. Conclusions: Preferential allocation of the normal cells into the trophoblast explains the absence of trophoblast overgrowth, a key feature of this syndrome. Interestingly, the distribution of androgenetic cells appears to differ from that reported for artificially created androgenetic mouse chimeras. Androgenetic mosaicism for the first time provides an aetiology for PMD, and may be a novel mechanism for BWS and unexplained intrauterine growth restriction.

1 January 2016 in Developmental Cell
Verified
Journal Article
Open access
MBMiguel Branco
Miguel Branco
MKMichelle King
Michelle King
VPVicente Pérez-García
Vicente Pérez-García
ABAaron B. Bogutz
Aaron B. Bogutz
MCMatthew Caley
Matthew Caley
WRWolf Reik
Wolf Reik
Critical roles for DNA methylation in embryonic development are well established, but less is known about its roles during trophoblast development, the extraembryonic lineage that gives rise to the placenta. We dissected the role of DNA methylation in trophoblast development by performing mRNA and DNA methylation profiling of Dnmt3a/3b mutants. We find that oocyte-derived methylation plays a major role in regulating trophoblast development but that imprinting of the key placental regulator Ascl2 is only partially responsible for these effects. We have identified several methylation-regulated genes associated with trophoblast differentiation that are involved in cell adhesion and migration, potentially affecting trophoblast invasion. Specifically, trophoblast-specific DNA methylation is linked to the silencing of Scml2, a Polycomb Repressive Complex 1 protein that drives loss of cell adhesion in methylation-deficient trophoblast. Our results reveal that maternal DNA methylation controls multiple differentiation-related and physiological processes in trophoblast via both imprinting-dependent and -independent mechanisms.